Immune checkpoint inhibitor-induced toxicity: a real-world analysis of the role of BMI
irAEs occurred more frequently in overweight/obese patients, mainly with metabolic abnormalities. These data underline the importance of a comprehensive clinical assessment, including weight and dysmetabolic comorbidities, of patients at baseline and during ICI therapy.
Authors
- Salvatore Cannavò (ORCID: https://orcid.org/0000-0001-8779-7283)
- Angela Alibrandi (ORCID: https://orcid.org/0000-0001-6695-151X)
- Massimiliano Berretta (ORCID: https://orcid.org/0000-0002-9837-9148)
- Desirèe Speranza (ORCID: https://orcid.org/0009-0005-5108-1052)
- Martina Laganà
- Rosaria Maddalena Ruggeri (ORCID: https://orcid.org/0000-0001-8899-684X)
- Calogera Claudia Spagnolo (ORCID: https://orcid.org/0000-0002-3352-2441)
- Mariacarmela Santarpia
Institutions
- University of Messina (IT)
- Azienda Ospedaliera Universitaria Policlinico "G. Martino" (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.3389/fonc.2025.1659977
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00